Category: Rheumatology/Arthritis
Rheumatology/Arthritis market research reports by DataM Intelligence 4Market Research LLP
-
Global Non-Oncology Biopharmaceuticals Market - 2025-2033
Non-Oncology Biopharmaceuticals Market - Industry Outlook Non-Oncology Biopharmaceuticals Market reached US$ 194.39 Billion in 2024 and is expected to reach US$ 313.70 Billion by 2033, growing at a CAGR of 5.5% during the forecast period 2025-2033. The global non-oncology biopharmaceuticals market i ... Read More
-
Global Rheumatoid Arthritis Drugs Market -2024-2031
Global Rheumatoid Arthritis Drugs Market -2024-2031 Global rheumatoid arthritis drugs market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031. Rheumatoid arthritis is a chronic inflammatory disorder that can ... Read More
-
Global Adalimumab Market - 2022-2029
Global Adalimumab Market - 2022-2029 Market Overview Adalimumab market was valued at USD 3829.40 million in 2021. It is forecasted to reach USD YY million by 2029, growing at a CAGR of 5.2% during the forecast period (2022-2029). Adalimumab is approved under the brand name Humira for the treatment o ... Read More
Research Assistance
